Evidence map›Paper›PMID 42145428›Full record

ArticleBioinformation2026

Urinary NGAL and NGAL/creatinine as tubular biomarkers in type 2 diabetes.

Prabhat Kumar Singh, Anand Vishal, Kirandeep Kamal, Saurav Das, Arbind Kumar Choudhary, Manish Kumar Thakur, Kiran Kumar Pasam

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Prabhat Kumar SinghDepartment of Medicine, ABVIMS and Dr. RML Hospital, New Delhi, India.
Anand VishalDepartment of Medicine, ABVIMS and Dr. RML Hospital, New Delhi, India.
Kirandeep KamalDepartment of Endocrinology, INHS Asvini, Mumbai, Maharashtra, India.
Saurav DasConsultant Endocrinologist, Marwari Hospitals and Research Centre, Guwahati, Assam, India.
Arbind Kumar ChoudharyDepartment of Pharmacology, Government Erode Medical College, Erode, Tamil Nadu, India.
Manish Kumar ThakurDepartment of Endocrinology, Atal Institute of Medical Sciences (AIMSS), Chamiana, Shimla, Himachal Pradesh, India.
Kiran Kumar PasamConsultant Endocrinologist, AIG Hospitals, Mindspace Road, Gachibowli, Hyderabad, Telangana, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic kidney disease (DKD) screening based on albuminuria and creatinine-derived eGFR may miss early tubular injury and normoalbuminuric renal impairment. Therefore, it is of interest to evaluate urinary neutrophil gelatinase-associated lipocalin (NGAL) and NGAL/creatinine ratio (NGAL/Cr) as complementary biomarkers in 70 patients with type 2 diabetes and 70 controls. NGAL and NGAL/Cr were higher in diabetes, correlated positively with albuminuria and inversely with eGFR and showed strong ROC discrimination for albuminuria. Urinary NGAL and NGAL/Cr may complement albuminuria and eGFR for early detection and risk stratification of DKD.

Indexed as

AlbuminuriaBiomarkerDiabetic kidney diseaseDiagnostic performanceeGFRNGAL/Creatinine ratioTubular injuryType 2 diabetes mellitusurinary neutrophil gelatinase-associated lipocalin (NGAL)

Identifiers

PMID42145428
PMCPMC13177091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.